Egill Masson - CEO @ Akthelia Pharmaceuticals

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

Egill Masson is the CEO at Akthelia Pharmaceuticals. He attended University of Copenhagen.

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Kerecis	New Business Venture Fund	Yes	Series A - Kerecis	obfuscated obfuscation
obfuscated obfuscation	Kerecis	New Business Venture Fund	—	Seed Round - Kerecis	obfuscated obfuscation

Number of Current Jobs

Number of Past Jobs

is the

CEO

. Additionally,

has had

past jobs including

Team Member - Business Intelligence

Organization Name	Title At Company	Start Date	End Date
Arion Bank	Team Member - Business Intelligence	—	—
Niels Bohr Institute	Programmer	—	—
CareFusion	Team Member - Marketing	—	—

Number of Current Board & Advisor Roles

Number of Past Board & Advisor Roles

holds

board and advisor roles including

Investment Advisory Board Member

Chairman of the Board of Directors

, and

Board member

Organization Name	Title At Company	Start Date	End Date
New Business Venture Fund	Board Member	May 2010	Jul 2017
Men&Mice	Chairman of the Board of Directors	—	2015
CLARA	Board Member	Jan 15, 2012	Apr 13, 2013
Kerecis	Member of the Board of Directors	—	—
Gogogic	Member of the Board of Directors	—	—

Hub Name	CB Rank (Hub)
Nordic Countries Biotechnology Companies	49,696
Gullbringusysla Female Founded Companies	80,066
Pharmaceutical Companies with Seed Funding	25,952
Europe Pharmaceutical Female Founded Companies	60,068
Medical Seed Stage Companies With Less Than $1M in Revenue	50,862
Pharmaceutical Female Founded Companies with Seed Funding	74,959
Scandinavia Female Founded Companies with Seed Funding	63,703
Pharmaceutical Seed Stage Companies With Less Than $500M in Revenue	43,669
Pharmaceutical Seed Stage Companies With Fewer Than 100 Employees	27,237
Horizon Europe Portfolio Companies	65,026